Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 8Lung Neoplasms 4Tobacco Use Disorder 3Neoplasms 3Head and Neck Neoplasms 3Tobacco Use Cessation 2Squamous Cell Carcinoma of Head and Neck 2Smoking 2Carcinoma, Non-Small-Cell Lung 2Vaping 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Tobacco Smoking 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Esophageal Neoplasms 1

Interventions

Varenicline 1Transdermal Patch 1Standard of Care 1Nicotine Replacement Therapy 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vaping × Varenicline × Clear all
NCT07040566 2025-12-17

A Trial of Varenicline for E-cigarette Cessation

Yale University

Phase 2 Recruiting
326 enrolled

Vaping, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡